Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia … J Tong, H Oyamada, N Demaurex, S Grinstein, TV McCarthy, ... Journal of Biological Chemistry 272 (42), 26332-26339, 1997 | 280 | 1997 |
Primary structure and distribution of ryanodine-binding protein isoforms of the bullfrog skeletal muscle. H Oyamada, T Murayama, T Takagi, M Iino, N Iwabe, T Miyata, Y Ogawa, ... Journal of Biological Chemistry 269 (25), 17206-17214, 1994 | 129 | 1994 |
Nitric oxide‐induced calcium release via ryanodine receptors regulates neuronal function S Kakizawa, T Yamazawa, Y Chen, A Ito, T Murayama, H Oyamada, ... The EMBO journal 31 (2), 417-428, 2012 | 113 | 2012 |
Further characterization of the type 3 ryanodine receptor (RyR3) purified from rabbit diaphragm T Murayama, T Oba, E Katayama, H Oyamada, K Oguchi, M Kobayashi, ... Journal of Biological Chemistry 274 (24), 17297-17308, 1999 | 109 | 1999 |
Engineering a novel multifunctional green fluorescent protein tag for a wide variety of protein research T Kobayashi, N Morone, T Kashiyama, H Oyamada, N Kurebayashi, ... PLoS One 3 (12), e3822, 2008 | 65 | 2008 |
Genotype–phenotype correlations of malignant hyperthermia and central core disease mutations in the central region of the RYR1 channel T Murayama, N Kurebayashi, H Ogawa, T Yamazawa, H Oyamada, ... Human Mutation 37 (11), 1231-1241, 2016 | 62 | 2016 |
Divergent activity profiles of type 1 ryanodine receptor channels carrying malignant hyperthermia and central core disease mutations in the amino-terminal region T Murayama, N Kurebayashi, T Yamazawa, H Oyamada, J Suzuki, ... PLoS One 10 (6), e0130606, 2015 | 54 | 2015 |
Regulation of serotonin transporter gene expression in human glial cells by growth factors N Kubota, Y Kiuchi, M Nemoto, H Oyamada, M Ohno, H Funahashi, ... European journal of pharmacology 417 (1-2), 69-76, 2001 | 51 | 2001 |
Efficient high-throughput screening by endoplasmic reticulum Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels T Murayama, N Kurebayashi, M Ishigami-Yuasa, S Mori, Y Suzuki, ... Molecular pharmacology 94 (1), 722-730, 2018 | 49 | 2018 |
MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine M Ishii, S Shimizu, Y Sakairi, A Nagamine, Y Naito, Y Hosaka, Y Naito, ... Molecular and cellular biochemistry 363, 357-366, 2012 | 47 | 2012 |
Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients H Oyamada, K Oguchi, N Saitoh, T Yamazawa, K Hirose, Y Kawana, ... Japanese journal of pharmacology 88 (2), 159-166, 2002 | 47 | 2002 |
Interaction between caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells T Iizaka, M Tsuji, H Oyamada, Y Morio, K Oguchi Toxicology 241 (3), 146-156, 2007 | 45 | 2007 |
Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines A Sasaki, Y Udaka, Y Tsunoda, G Yamamoto, M Tsuji, H Oyamada, ... Anticancer research 32 (11), 4709-4713, 2012 | 42 | 2012 |
Overexpression of ryanodine receptor type 1 enhances mitochondrial fragmentation and Ca2+-induced ATP production in cardiac H9c2 myoblasts J O-Uchi, BS Jhun, S Hurst, S Bisetto, P Gross, M Chen, S Kettlewell, ... American Journal of Physiology-Heart and Circulatory Physiology 305 (12 …, 2013 | 37 | 2013 |
Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel … GG DU, H OYAMADA, VK KHANNA, DH MacLENNAN Biochemical Journal 360 (1), 97-105, 2001 | 31 | 2001 |
Dominant-negative Connexin43–EGFP inhibits calcium-transient synchronization of primary neonatal rat cardiomyocytes Y Oyamada, W Zhou, H Oyamada, T Takamatsu, M Oyamada Experimental cell research 273 (1), 85-94, 2002 | 30 | 2002 |
Decreased miR-206 expression in BRCA1 wild-type triple-negative breast cancer cells after concomitant treatment with gemcitabine and a Poly (ADP-ribose) polymerase-1 inhibitor A Sasaki, Y Tsunoda, M Tsuji, Y Udaka, H Oyamada, H Tsuchiya, ... Anticancer Research 34 (9), 4893-4897, 2014 | 29 | 2014 |
Ethanol-induced apoptosis in human liver adenocarcinoma cells (SK-Hep1): Fas-and mitochondria-mediated pathways and interaction with MAPK signaling system Y Morio, M Tsuji, M Inagaki, M Nakagawa, Y Asaka, H Oyamada, ... Toxicology in Vitro 27 (6), 1820-1829, 2013 | 25 | 2013 |
Effects of ryanodine on the properties of Ca2+ release from the sarcoplasmic reticulum in skinned skeletal muscle fibres of the frog. H Oyamada, M Iino, M Endo The Journal of Physiology 470 (1), 335-348, 1993 | 25 | 1993 |
Role of amino-terminal half of the S4-S5 linker in type 1 ryanodine receptor (RyR1) channel gating T Murayama, N Kurebayashi, T Oba, H Oyamada, K Oguchi, T Sakurai, ... Journal of Biological Chemistry 286 (41), 35571-35577, 2011 | 23 | 2011 |